Of note, 5 of the 6 patients with SLE with anti-Ro52 and anti-Ro60 autoantibodies were taking an immunosuppressive agent at the time of this study, an important confounder that could also explain these results. Here, TRIM21 is linked to systemic lupus erythematosus.